MPO and COVID-19: Follow-up studies further showed that NET-associated markers in patient sera, including citrullinated histone H3 (Cit-H3), cell-free DNA, myeloperoxidase-DNA complexes (MPO-DNA), and calprotectin, were associated with higher risk of thrombotic events in patients with COVID-19 (26).